| Unknown | Argatroban Monitoring in Acute Suspected Heparin-induced Thrombocytopenia. NCT06066762 | Assistance Publique - Hôpitaux de Paris | — |
| Terminated | A Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia NCT05785819 | Veralox Therapeutics | Phase 2 |
| Recruiting | Characterization and Quantification of Platelet/Leukocyte Aggregates in Patients With Suspected Heparin-induce NCT06033300 | Centre Hospitalier Universitaire, Amiens | N/A |
| Unknown | Comparison of Pre-test Probability Model for Heparin-induced Thrombocytopenia in Post-operative Cardiac Surger NCT05783895 | Central Hospital, Nancy, France | — |
| Unknown | Multicenter Study on Dialysis Modalities for End-stage Chronic Renal Failure Patients With Heparin-induced Thr NCT05586854 | Ramsay Générale de Santé | N/A |
| Completed | A Phase I Study of the Co-administration of VLX-1005 and Argatroban in Healthy Human Subjects NCT05325346 | Veralox Therapeutics | Phase 1 |
| Unknown | PLATELET Function Assay With Flow Imaging on ImageSTREAM Cytometer NCT04842760 | Centre Hospitalier Universitaire, Amiens | — |
| Unknown | Evaluation of the Intra-observer Agreement of the HEP Score in Surgical Intensive Care. NCT04782843 | Centre Hospitalier Universitaire de Besancon | — |
| Unknown | Argatroban Monitoring in Critically Ill Patients: Evaluation of a Novel Ecarin-based Bedside Test NCT04751357 | Medical University of Vienna | — |
| Terminated | Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Arg NCT03809481 | Aspen Global Incorporated | Phase 3 |
| Terminated | Efficacy and Safety of Apixaban in the Treatment of Heparin Induced Thrombocytopenia (HIT) NCT03594045 | Massachusetts General Hospital | Phase 2 |
| Unknown | Thrombotic Biomarkers to Predict Thrombosis in Heparin-induced Thrombocytopenia NCT03269019 | Wuhan Asia Heart Hospital | — |
| Unknown | Multi-Center Single Arm Trial to Determine The Effectiveness of Warfarin Therapy Duration For Heparin-Induced NCT03147638 | Marshall University | Phase 3 |
| Recruiting | Pharmacogenomics of Heparin-Induced Thrombocytopenia NCT02717039 | University of Arizona | — |
| Completed | Prognosis Related to Induced Thrombopenia With Heparin Under Venoarterial ECMO in Reanimation NCT03979625 | Central Hospital, Nancy, France | — |
| Completed | Immunogenetics of Heparin-Induced Thrombocytopenia: Aim 2 NCT02526485 | Vanderbilt University Medical Center | — |
| Terminated | Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced Thrombocytopenia NCT01598168 | McMaster University | Phase 3 |
| Completed | Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study NCT01178333 | Carelon Research | — |
| Unknown | Generation of Heparin-induced Thrombocytopenia (HIT)-Antibodies Without Prior Heparin Exposure NCT01102790 | Johann Wolfgang Goethe University Hospital | — |
| Completed | Heparin-induced Thrombocytopenia (HIT II) in Liver Transplant Recipients NCT01654848 | CHIR-Net | — |
| Unknown | Validating 4Ts for Heparin Induced Thrombocytopenia (HIT) NCT00946400 | Medstar Health Research Institute | — |
| Completed | Heparin-Induced Thrombocytopenia: Development and Validation of a Predictive Clinical NCT00748839 | Centre Hospitalier Universitaire de Saint Etienne | — |
| Withdrawn | Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis S NCT00759083 | The Medicines Company | Phase 4 |
| Withdrawn | Fondaparinux in Patients With Acute Heparin-Induced Thrombocytopenia (HIT) NCT00603824 | Methodist Healthcare | Phase 4 |
| Completed | Heparin-Induced Thrombocytopenia Score Card Study NCT00489437 | McMaster University | Phase 1 |
| Terminated | Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT) NCT00673439 | University of Louisville | Phase 2 |
| Completed | Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis NCT00412464 | Children's Hospital Los Angeles | Phase 1 |
| Completed | Heparin-Induced Thrombocytopenia Registry NCT00456326 | Brigham and Women's Hospital | — |
| Completed | Efficacy and Safety Study of Argatroban to Treat Heparin-Induced Thrombocytopenia NCT00198588 | Ministry of Health, Labour and Welfare, Japan | Phase 3 |
| Unknown | A Study on the Prevalence of Heparin-Induced Thrombocytopenia in Cardiovascular Patients NCT00198575 | Ministry of Health, Labour and Welfare, Japan | — |
| Completed | Heparin Antibodies in Intensive Care Unit Patients (HAICU) NCT00283322 | The University of Texas Health Science Center, Houston | — |
| Unknown | The HIT-TRAP Trial NCT00196417 | University Medicine Greifswald | Phase 4 |
| Completed | Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients Wi NCT00043940 | The Medicines Company | Phase 3 |